Contact

Let's talk.

For investor inquiries, clinical collaboration, partnership discussions, or media — reach out below or email us directly.

Direct

Reach Rob directly.

The fastest path is email. Rob personally reads every message and replies within one business day. Please mention your role (investor, clinician, partner, media) so we can route the conversation appropriately.

  • Investors Mention "investor" in your message and we'll send a deck and data-room access promptly.
  • Clinicians & researchers For clinical collaboration, validation study questions, or scientific dialogue.
  • Press & media For interview requests, statements, or background briefings.

Send us a message

We'll reply within one business day.

A note on confidentiality

We treat investor and clinical conversations seriously.

Materials shared in private investor and clinical-collaboration conversations — including performance data, financial projections, IP details, and validation study materials — are treated as confidential. We're happy to sign mutual NDAs where appropriate.